U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958328) titled 'Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer' on April 25.
Brief Summary: This phase III trial compares the effect of dose-escalated radiation therapy to usual care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who have received an initial 4-6 months of chemotherapy. Usual care options include additional chemotherapy, observation, or standard lower-dose radiation therapy. These treatments may delay tumor growth but have not been shown to improve survival. Radiation therapy uses high energy X-rays to kill cancer cells and shrink tumors. Dose-escalated radiation therapy i...